نتایج جستجو برای: fgfr3

تعداد نتایج: 1106  

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2006
Xiaohua Xin Tinya J Abrams Paul W Hollenbach Katherine G Rendahl Yan Tang Yoko A Oei Millicent G Embry Debbie E Swinarski Evelyn N Garrett Nancy K Pryer Suzanne Trudel Bahija Jallal Dirk B Mendel Carla C Heise

PURPOSE The ectopically expressed and deregulated fibroblast growth factor receptor 3 (FGFR3) results from a t(4;14) chromosomal translocation that occurs in approximately 15% of multiple myeloma (MM) patients and confers a particularly poor prognosis. This study assesses the antimyeloma activity of CHIR-258, a small-molecule inhibitor of multiple receptor tyrosine kinases that is currently in ...

2014
Tao Ren Yi Qing Nan Dai Mengxia Li Chengyuan Qian Yuxin Yang Yi Cheng Zheng Li Shiheng Zhang Zhaoyang Zhong Dong Wang

Tumor angiogenesis contributes to inferior prognosis in osteosarcoma. Apurinic/apyrimidinic endonuclease 1 (APE1) and fibroblast growth factor 2 (FGF2) and its receptor 3 (FGFR3) signaling pathway plays an important role in the angiogenic process. In this study we observed that high expression of APE1, FGF2 and FGFR3, and microvessel density are positively correlated with poor prognosis of oste...

Journal: :Molecular cancer research : MCR 2014
Jaime Acquaviva Suqin He Chaohua Zhang John-Paul Jimenez Masazumi Nagai Jim Sang Manuel Sequeira Donald L Smith Luisa Shin Ogawa Takayo Inoue Noriaki Tatsuta Margaret A Knowles Richard C Bates David A Proia

UNLABELLED Activating mutations and/or overexpression of FGFR3 are common in bladder cancer, making FGFR3 an attractive therapeutic target in this disease. In addition, FGFR3 gene rearrangements have recently been described that define a unique subset of bladder tumors. Here, a selective HSP90 inhibitor, ganetespib, induced loss of FGFR3-TACC3 fusion protein expression and depletion of multiple...

Journal: :The Journal of clinical investigation 2009
Yaron Hadari Joseph Schlessinger

Gain-of-function mutations in FGF receptor 3 (FGFR3) have been implicated in severe skeletal dysplasias and in a variety of cancers. In their study in this issue of the JCI, Qing et al. used specific shRNA probes to demonstrate that FGFR3 functions as an important driver of bladder carcinoma cell proliferation (see the related article beginning on page 1216). A unique anti-FGFR3 mAb was shown t...

Journal: :Journal of the National Cancer Institute 2012
André F S Amaral Marinela Méndez-Pertuz Alberto Muñoz Debra T Silverman Yves Allory Manolis Kogevinas Josep Lloreta Nathaniel Rothman Alfredo Carrato Manuel Rivas del Fresno Francisco X Real Núria Malats

BACKGROUND Previous evidence suggests that 25-hydroxyvitamin D(3) [25(OH)D(3)] protects against several cancers. However, little is known regarding urothelial bladder cancer (UBC). We analyzed the association between plasma 25(OH)D(3) and overall risk of UBC, as well as according to stage and FGFR3 molecular subphenotypes. METHODS Plasma concentrations of 25(OH)D(3) in 1125 cases with UBC and...

Reza Gharaee, Shahin Mafinezhad Yasaman Bozorgnia,

  Thanatophoricdysplasia (TD) isanosteochondrodysplasiaalwayslethalintheneonatalperiod. Thevastmajorityofcasesareduetodenovomutations. Itisdividedintotwotypes: ashortcurvedfemurcharacterizestype 1, whileastraighterfemurwithcloverleafskullcharacterizestype 2. Inthanatophoricdysplasiathelimbsareveryshort. Theribcageissmall. Thevertebralbodiesofthespinearegreatlyreducedinheightwithwidespacesbetwee...

Journal: :The Journal of neuroscience : the official journal of the Society for Neuroscience 2002
Kristen L Mueller Bonnie E Jacques Matthew W Kelley

One of the most striking aspects of the cellular pattern within the sensory epithelium of the mammalian cochlea is the presence of two rows of pillar cells in the region between the single row of inner hair cells and the first row of outer hair cells. The factors that regulate pillar cell development have not been determined; however, previous results suggested a key role for fibroblast growth ...

2011
Ellen Margrethe Haugsten Malgorzata Zakrzewska Andreas Brech Sascha Pust Sjur Olsnes Kirsten Sandvig Jørgen Wesche

Endocytosis of tyrosine kinase receptors can influence both the duration and the specificity of the signal emitted. We have investigated the mechanisms of internalization of fibroblast growth factor receptor 3 (FGFR3) and compared it to that of FGFR1 which is internalized predominantly through clathrin-mediated endocytosis. Interestingly, we observed that FGFR3 was internalized at a slower rate...

Journal: :Human molecular genetics 2010
Nan Su Qidi Sun Can Li Xiumin Lu Huabing Qi Siyu Chen Jing Yang Xiaolan Du Ling Zhao Qifen He Min Jin Yue Shen Di Chen Lin Chen

Achondroplasia (ACH) is a short-limbed dwarfism resulting from gain-of-function mutations in fibroblast growth factor receptor 3 (FGFR3). Previous studies have shown that ACH patients have impaired chondrogenesis, but the effects of FGFR3 on bone formation and bone remodeling at adult stages of ACH have not been fully investigated. Using micro-computed tomography and histomorphometric analyses,...

2016
Willemijn SME Theelen Lorenza Mittempergher Stefan M Willems Astrid J Bosma Dennis DGC Peters Vincent van der Noort Eva J Japenga Ton Peeters Koos Koole Tonći Šuštić JL Blaauwgeers Carel J van Noesel René Bernards Michel M van den Heuvel

This study aimed to determine protein expression levels of fibroblast growth factor receptors (FGFR) 1, 2 and 3 in early stage non-small cell lung cancer (NSCLC). Additionally, a screen to define the frequency of FGFR3-TACC3 translocation and FGFR3 amplification was performed. Archived tissues from 653 NSCLC samples (adenocarcinoma (AC), squamous cell carcinoma (SCC) and large cell carcinoma (L...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید